{"transactions":[{"id":4638373,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:59:35.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":256000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1892616/000119312526418329/ownership.xml","form_type":"4"}},{"id":4638372,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:59:35.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":95933,"price":38.61,"value":3703973.13,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":183248,"source":{"system":"sec-edgar","filing":"0001193125-26-418329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1892616/000119312526418329/ownership.xml","form_type":"4"}},{"id":4638371,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:59:35.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":62300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2026 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":279181,"source":{"system":"sec-edgar","filing":"0001193125-26-418329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1892616/000119312526418329/ownership.xml","form_type":"4"}},{"id":4638370,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:59:35.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":76204,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\"). In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2025 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":216881,"source":{"system":"sec-edgar","filing":"0001193125-26-418329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1892616/000119312526418329/ownership.xml","form_type":"4"}},{"id":4624847,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-22T21:11:33.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":937,"price":36.69,"value":34378.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":211286,"source":{"system":"sec-edgar","filing":"0001628280-26-063075","document":"wk-form4_1790111490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1892616/000162828026063075/wk-form4_1790111490.xml","form_type":"4"}},{"id":4614848,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-10T20:50:26.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1026,"price":35.38,"value":36299.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":212223,"source":{"system":"sec-edgar","filing":"0001628280-26-061387","document":"wk-form4_1789073424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1892616/000162828026061387/wk-form4_1789073424.xml","form_type":"4"}},{"id":710886,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-13T21:03:37.000Z","date":"2026-07-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":844,"price":27.79,"value":23454.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":213249,"source":{"system":"sec-edgar","filing":"0001628280-26-048054","document":"wk-form4_1783976614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026048054/wk-form4_1783976614.xml","form_type":"4"}},{"id":731236,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:50:08.000Z","date":"2026-06-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":937,"price":26.04,"value":24399.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":214093,"source":{"system":"sec-edgar","filing":"0001628280-26-044695","document":"wk-form4_1782161406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026044695/wk-form4_1782161406.xml","form_type":"4"}},{"id":743887,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-10T21:01:33.000Z","date":"2026-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1026,"price":26.1,"value":26778.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":215030,"source":{"system":"sec-edgar","filing":"0001628280-26-042286","document":"wk-form4_1781125288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026042286/wk-form4_1781125288.xml","form_type":"4"}},{"id":810863,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-10T21:29:11.000Z","date":"2026-04-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":844,"price":19.27,"value":16263.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":216056,"source":{"system":"sec-edgar","filing":"0001628280-26-024765","document":"wk-form4_1775856548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026024765/wk-form4_1775856548.xml","form_type":"4"}},{"id":831553,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-23T21:08:47.000Z","date":"2026-03-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":3749,"price":19.12,"value":71680.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":216900,"source":{"system":"sec-edgar","filing":"0001628280-26-020578","document":"wk-form4_1774300124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026020578/wk-form4_1774300124.xml","form_type":"4"}},{"id":859863,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T22:10:17.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":588,"price":20.74,"value":12195.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":220649,"source":{"system":"sec-edgar","filing":"0001628280-26-015339","document":"wk-form4_1772748614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026015339/wk-form4_1772748614.xml","form_type":"4"}},{"id":880793,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:56:06.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":25525,"price":22.65,"value":578141.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":221237,"source":{"system":"sec-edgar","filing":"0001628280-26-012479","document":"wk-form4_1772146564.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012479/wk-form4_1772146564.xml","form_type":"4"}},{"id":880792,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:56:06.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":64866,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":246762,"source":{"system":"sec-edgar","filing":"0001628280-26-012479","document":"wk-form4_1772146564.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012479/wk-form4_1772146564.xml","form_type":"4"}},{"id":880791,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:56:06.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":31150,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation."}],"balance_after":181896,"source":{"system":"sec-edgar","filing":"0001628280-26-012479","document":"wk-form4_1772146564.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012479/wk-form4_1772146564.xml","form_type":"4"}},{"id":943691,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-08T22:04:31.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":990,"price":25.59,"value":25334.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":150746,"source":{"system":"sec-edgar","filing":"0001628280-26-001387","document":"wk-form4_1767909868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026001387/wk-form4_1767909868.xml","form_type":"4"}},{"id":966119,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-17T22:26:14.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":1033,"price":25.13,"value":25959.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":151736,"source":{"system":"sec-edgar","filing":"0001628280-25-057723","document":"wk-form4_1766010371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025057723/wk-form4_1766010371.xml","form_type":"4"}},{"id":979668,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-05T23:44:10.000Z","date":"2025-12-04","kind":"sale","planned":false,"acquired":false,"shares":30000,"price":25.72,"value":771600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.53 to $25.84, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":152769,"source":{"system":"sec-edgar","filing":"0001628280-25-055636","document":"wk-form4_1764978247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025055636/wk-form4_1764978247.xml","form_type":"4"}},{"id":986398,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-28T22:35:40.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":584,"price":26.74,"value":15616.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":182769,"source":{"system":"sec-edgar","filing":"0001628280-25-054282","document":"wk-form4_1764369337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025054282/wk-form4_1764369337.xml","form_type":"4"}},{"id":1019739,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-14T21:30:56.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":833,"price":27.36,"value":22790.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":183353,"source":{"system":"sec-edgar","filing":"0001628280-25-045019","document":"wk-form4_1760477454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025045019/wk-form4_1760477454.xml","form_type":"4"}},{"id":1041003,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-15T21:02:12.000Z","date":"2025-09-11","kind":"sale","planned":true,"acquired":false,"shares":1032,"price":26.83,"value":27688.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":184186,"source":{"system":"sec-edgar","filing":"0001892616-25-000004","document":"wk-form4_1757970129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000189261625000004/wk-form4_1757970129.xml","form_type":"4"}},{"id":1054154,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-28T21:07:11.000Z","date":"2025-08-26","kind":"sale","planned":true,"acquired":false,"shares":590,"price":25.44,"value":15009.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":185218,"source":{"system":"sec-edgar","filing":"0001628280-25-041301","document":"wk-form4_1756415228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025041301/wk-form4_1756415228.xml","form_type":"4"}},{"id":1090325,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-09T21:54:23.000Z","date":"2025-07-07","kind":"sale","planned":true,"acquired":false,"shares":877,"price":22.27,"value":19530.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":185808,"source":{"system":"sec-edgar","filing":"0001628280-25-034683","document":"wk-form4_1752098056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025034683/wk-form4_1752098056.xml","form_type":"4"}},{"id":1114246,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-12T21:24:18.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":1042,"price":23.7,"value":24695.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":186685,"source":{"system":"sec-edgar","filing":"0001628280-25-031101","document":"wk-form4_1749763452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025031101/wk-form4_1749763452.xml","form_type":"4"}},{"id":1129930,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-30T21:54:44.000Z","date":"2025-05-28","kind":"sale","planned":true,"acquired":false,"shares":583,"price":22.46,"value":13094.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":187727,"source":{"system":"sec-edgar","filing":"0001628280-25-028692","document":"wk-form4_1748642060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025028692/wk-form4_1748642060.xml","form_type":"4"}},{"id":1173650,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-11T21:49:43.000Z","date":"2025-04-09","kind":"sale","planned":true,"acquired":false,"shares":932,"price":20.11,"value":18742.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":188310,"source":{"system":"sec-edgar","filing":"0001628280-25-017589","document":"wk-form4_1744408177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025017589/wk-form4_1744408177.xml","form_type":"4"}},{"id":1181305,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-03T21:48:22.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":25687,"price":22.66,"value":582067.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":189242,"source":{"system":"sec-edgar","filing":"0001628280-25-016635","document":"wk-form4_1743716896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025016635/wk-form4_1743716896.xml","form_type":"4"}},{"id":1196271,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-20T23:07:56.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":60018,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 175% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":214929,"source":{"system":"sec-edgar","filing":"0001628280-25-014182","document":"wk-form4_1742512070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025014182/wk-form4_1742512070.xml","form_type":"4"}},{"id":1196270,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-20T23:07:56.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":38102,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2025 compensation."}],"balance_after":154911,"source":{"system":"sec-edgar","filing":"0001628280-25-014182","document":"wk-form4_1742512070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025014182/wk-form4_1742512070.xml","form_type":"4"}},{"id":1208507,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-13T21:25:53.000Z","date":"2025-03-11","kind":"sale","planned":true,"acquired":false,"shares":4151,"price":25,"value":103775.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":116809,"source":{"system":"sec-edgar","filing":"0001628280-25-012677","document":"wk-form4_1741901146.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025012677/wk-form4_1741901146.xml","form_type":"4"}},{"id":1224605,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T22:13:28.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":660,"price":25.46,"value":16803.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":120960,"source":{"system":"sec-edgar","filing":"0001628280-25-010564","document":"wk-form4_1741212802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025010564/wk-form4_1741212802.xml","form_type":"4"}},{"id":1268568,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-14T22:47:02.000Z","date":"2025-02-12","kind":"sale","planned":true,"acquired":false,"shares":159,"price":26.54,"value":4219.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":121620,"source":{"system":"sec-edgar","filing":"0001628280-25-005843","document":"wk-form4_1739573216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025005843/wk-form4_1739573216.xml","form_type":"4"}},{"id":1307231,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-09T00:10:25.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":987,"price":27.02,"value":26668.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":121779,"source":{"system":"sec-edgar","filing":"0001628280-25-000982","document":"wk-form4_1736381417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025000982/wk-form4_1736381417.xml","form_type":"4"}},{"id":1348645,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-29T22:30:14.000Z","date":"2024-11-26","kind":"sale","planned":true,"acquired":false,"shares":581,"price":27.2,"value":15803.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":122766,"source":{"system":"sec-edgar","filing":"0001628280-24-049480","document":"wk-form4_1732919407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024049480/wk-form4_1732919407.xml","form_type":"4"}},{"id":1365870,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-14T23:37:42.000Z","date":"2024-11-12","kind":"sale","planned":true,"acquired":false,"shares":147,"price":26.19,"value":3849.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":123347,"source":{"system":"sec-edgar","filing":"0001628280-24-047992","document":"wk-form4_1731627455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024047992/wk-form4_1731627455.xml","form_type":"4"}},{"id":1378523,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-01T23:01:26.000Z","date":"2024-10-30","kind":"sale","planned":true,"acquired":false,"shares":894,"price":23.15,"value":20696.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":123494,"source":{"system":"sec-edgar","filing":"0001628280-24-044811","document":"wk-form4_1730502079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024044811/wk-form4_1730502079.xml","form_type":"4"}},{"id":1404143,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-18T21:44:53.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":611,"price":25.12,"value":15348.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":124388,"source":{"system":"sec-edgar","filing":"0001628280-24-040830","document":"wk-form4_1726695887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024040830/wk-form4_1726695887.xml","form_type":"4"}},{"id":1404142,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-18T21:44:53.000Z","date":"2024-08-21","kind":"sale","planned":true,"acquired":false,"shares":142,"price":25.61,"value":3636.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":124999,"source":{"system":"sec-edgar","filing":"0001628280-24-040830","document":"wk-form4_1726695887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024040830/wk-form4_1726695887.xml","form_type":"4"}},{"id":1404141,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-18T21:44:53.000Z","date":"2024-07-11","kind":"sale","planned":true,"acquired":false,"shares":828,"price":20.54,"value":17007.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":125141,"source":{"system":"sec-edgar","filing":"0001628280-24-040830","document":"wk-form4_1726695887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024040830/wk-form4_1726695887.xml","form_type":"4"}},{"id":1497221,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T21:05:14.000Z","date":"2024-05-29","kind":"sale","planned":true,"acquired":false,"shares":574,"price":21.78,"value":12501.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":125969,"source":{"system":"sec-edgar","filing":"0001628280-24-026081","document":"wk-form4_1717189506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024026081/wk-form4_1717189506.xml","form_type":"4"}},{"id":1507987,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-21T12:13:24.000Z","date":"2024-05-17","kind":"sale","planned":true,"acquired":false,"shares":115,"price":22.18,"value":2550.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":126543,"source":{"system":"sec-edgar","filing":"0001628280-24-024447","document":"wk-form4_1716293596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024024447/wk-form4_1716293596.xml","form_type":"4"}},{"id":1537186,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-23T23:14:10.000Z","date":"2024-04-18","kind":"sale","planned":true,"acquired":false,"shares":956,"price":15.31,"value":14636.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":126658,"source":{"system":"sec-edgar","filing":"0001628280-24-017495","document":"wk-form4_1713914040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024017495/wk-form4_1713914040.xml","form_type":"4"}},{"id":1562600,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-25T21:03:11.000Z","date":"2024-03-21","kind":"sale","planned":true,"acquired":false,"shares":520,"price":17.83,"value":9271.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-19-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":127614,"source":{"system":"sec-edgar","filing":"0001628280-24-012933","document":"wk-form4_1711400581.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024012933/wk-form4_1711400581.xml","form_type":"4"}},{"id":1582765,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:43:21.000Z","date":"2024-03-12","kind":"sale","planned":true,"acquired":false,"shares":7249,"price":16.6,"value":120333.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":128134,"source":{"system":"sec-edgar","filing":"0001628280-24-010743","document":"wk-form4_1710294189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010743/wk-form4_1710294189.xml","form_type":"4"}},{"id":1582764,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:43:21.000Z","date":"2024-03-11","kind":"sale","planned":true,"acquired":false,"shares":361,"price":17.42,"value":6288.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":135383,"source":{"system":"sec-edgar","filing":"0001628280-24-010743","document":"wk-form4_1710294189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010743/wk-form4_1710294189.xml","form_type":"4"}},{"id":1582763,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:43:21.000Z","date":"2024-03-08","kind":"grant","planned":true,"acquired":true,"shares":29206,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 125% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2022 through December 31, 2023 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":135744,"source":{"system":"sec-edgar","filing":"0001628280-24-010743","document":"wk-form4_1710294189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010743/wk-form4_1710294189.xml","form_type":"4"}},{"id":1582762,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:43:21.000Z","date":"2024-03-08","kind":"grant","planned":true,"acquired":true,"shares":41715,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2024 compensation."}],"balance_after":106538,"source":{"system":"sec-edgar","filing":"0001628280-24-010743","document":"wk-form4_1710294189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010743/wk-form4_1710294189.xml","form_type":"4"}},{"id":1623692,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-23T22:51:55.000Z","date":"2024-02-21","kind":"sale","planned":true,"acquired":false,"shares":97,"price":17.35,"value":1682.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":64823,"source":{"system":"sec-edgar","filing":"0001628280-24-006709","document":"wk-form4_1708728703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024006709/wk-form4_1708728703.xml","form_type":"4"}},{"id":1673593,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-23T22:29:48.000Z","date":"2024-01-19","kind":"sale","planned":true,"acquired":false,"shares":2419,"price":16.76,"value":40542.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":64920,"source":{"system":"sec-edgar","filing":"0001628280-24-001981","document":"wk-form4_1706048979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024001981/wk-form4_1706048979.xml","form_type":"4"}},{"id":1699090,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-28T21:46:55.000Z","date":"2023-12-22","kind":"sale","planned":true,"acquired":false,"shares":314,"price":16.79,"value":5272.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-19-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":67339,"source":{"system":"sec-edgar","filing":"0001628280-23-042810","document":"wk-form4_1703800002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023042810/wk-form4_1703800002.xml","form_type":"4"}},{"id":1702762,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-21T20:44:32.000Z","date":"2023-12-03","kind":"grant","planned":false,"acquired":true,"shares":287,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":67653,"source":{"system":"sec-edgar","filing":"0001628280-23-042480","document":"wk-form4_1703191464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023042480/wk-form4_1703191464.xml","form_type":"4"}},{"id":1705932,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-19T22:54:53.000Z","date":"2023-12-17","kind":"grant","planned":false,"acquired":true,"shares":254,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":67366,"source":{"system":"sec-edgar","filing":"0001628280-23-042031","document":"wk-form4_1703026481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023042031/wk-form4_1703026481.xml","form_type":"4"}},{"id":1724588,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-05T00:14:15.000Z","date":"2023-12-01","kind":"sale","planned":true,"acquired":false,"shares":666,"price":12.37,"value":8238.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":67112,"source":{"system":"sec-edgar","filing":"0001628280-23-040672","document":"wk-form4_1701735246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023040672/wk-form4_1701735246.xml","form_type":"4"}},{"id":1724587,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-05T00:14:15.000Z","date":"2023-11-19","kind":"grant","planned":true,"acquired":true,"shares":298,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":67778,"source":{"system":"sec-edgar","filing":"0001628280-23-040672","document":"wk-form4_1701735246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023040672/wk-form4_1701735246.xml","form_type":"4"}},{"id":1741559,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-15T15:40:50.000Z","date":"2023-11-13","kind":"sale","planned":true,"acquired":false,"shares":97,"price":10.66,"value":1034.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":67480,"source":{"system":"sec-edgar","filing":"0001628280-23-039095","document":"wk-form4_1700062841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023039095/wk-form4_1700062841.xml","form_type":"4"}},{"id":1745087,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-13T21:40:48.000Z","date":"2023-11-05","kind":"grant","planned":false,"acquired":true,"shares":333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":67577,"source":{"system":"sec-edgar","filing":"0001628280-23-038652","document":"wk-form4_1699911624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023038652/wk-form4_1699911624.xml","form_type":"4"}},{"id":1755974,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-24T23:44:59.000Z","date":"2023-10-22","kind":"grant","planned":false,"acquired":true,"shares":373,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":67244,"source":{"system":"sec-edgar","filing":"0001628280-23-035025","document":"wk-form4_1698191090.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023035025/wk-form4_1698191090.xml","form_type":"4"}},{"id":1763045,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-10T21:25:21.000Z","date":"2023-10-08","kind":"grant","planned":false,"acquired":true,"shares":281,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":66871,"source":{"system":"sec-edgar","filing":"0001628280-23-034199","document":"wk-form4_1696973109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023034199/wk-form4_1696973109.xml","form_type":"4"}},{"id":1771052,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-02T21:02:20.000Z","date":"2023-09-24","kind":"grant","planned":false,"acquired":true,"shares":290,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":66590,"source":{"system":"sec-edgar","filing":"0001628280-23-033502","document":"wk-form4_1696280531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023033502/wk-form4_1696280531.xml","form_type":"4"}},{"id":1774291,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-25T20:57:39.000Z","date":"2023-09-21","kind":"sale","planned":true,"acquired":false,"shares":539,"price":12.7,"value":6845.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-19-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":66300,"source":{"system":"sec-edgar","filing":"0001628280-23-032947","document":"wk-form4_1695675448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023032947/wk-form4_1695675448.xml","form_type":"4"}},{"id":1783474,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-12T20:48:24.000Z","date":"2023-09-10","kind":"grant","planned":false,"acquired":true,"shares":408,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":66839,"source":{"system":"sec-edgar","filing":"0001628280-23-032090","document":"wk-form4_1694551695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023032090/wk-form4_1694551695.xml","form_type":"4"}},{"id":1793688,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-30T21:39:02.000Z","date":"2023-08-27","kind":"grant","planned":false,"acquired":true,"shares":498,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":66431,"source":{"system":"sec-edgar","filing":"0001628280-23-031006","document":"wk-form4_1693431531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023031006/wk-form4_1693431531.xml","form_type":"4"}},{"id":1794693,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-29T21:51:13.000Z","date":"2023-08-25","kind":"sale","planned":true,"acquired":false,"shares":585,"price":10.99,"value":6429.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":65933,"source":{"system":"sec-edgar","filing":"0001628280-23-030912","document":"wk-form4_1693345863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023030912/wk-form4_1693345863.xml","form_type":"4"}},{"id":1806712,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-16T20:47:20.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":94,"price":12.57,"value":1181.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":66518,"source":{"system":"sec-edgar","filing":"0001628280-23-029683","document":"wk-form4_1692218830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023029683/wk-form4_1692218830.xml","form_type":"4"}},{"id":1844692,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-26T20:36:00.000Z","date":"2023-06-22","kind":"sale","planned":true,"acquired":false,"shares":541,"price":23.41,"value":12664.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-19-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":66612,"source":{"system":"sec-edgar","filing":"0001628280-23-023458","document":"wk-form4_1687811752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023023458/wk-form4_1687811752.xml","form_type":"4"}},{"id":1871092,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-03T00:01:33.000Z","date":"2023-05-31","kind":"sale","planned":true,"acquired":false,"shares":560,"price":23.21,"value":12997.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":67153,"source":{"system":"sec-edgar","filing":"0001437749-23-016545","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923016545/rdgdoc.xml","form_type":"4"}},{"id":1890403,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-18T01:51:47.000Z","date":"2023-05-16","kind":"sale","planned":true,"acquired":false,"shares":137,"price":19.41,"value":2659.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":67713,"source":{"system":"sec-edgar","filing":"0001437749-23-015001","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923015001/rdgdoc.xml","form_type":"4"}},{"id":1942263,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2023-03-22T23:59:01.000Z","date":"2023-03-20","kind":"exercise","planned":false,"acquired":false,"shares":938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of September 15, 2022."}],"balance_after":0,"derivative":{"exercise_price":2.06,"expiration_date":"2025-05-04","underlying":"Common Stock","underlying_shares":938},"source":{"system":"sec-edgar","filing":"0001437749-23-007564","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923007564/rdgdoc.xml","form_type":"4"}},{"id":1942262,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-22T23:59:01.000Z","date":"2023-03-22","kind":"sale","planned":false,"acquired":false,"shares":310,"price":21.84,"value":6770.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":67850,"source":{"system":"sec-edgar","filing":"0001437749-23-007564","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923007564/rdgdoc.xml","form_type":"4"}},{"id":1942261,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-22T23:59:01.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":20.64,"value":206400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.47 to $20.76, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":68160,"source":{"system":"sec-edgar","filing":"0001437749-23-007564","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923007564/rdgdoc.xml","form_type":"4"}},{"id":1942260,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-22T23:59:01.000Z","date":"2023-03-20","kind":"exercise","planned":false,"acquired":true,"shares":938,"price":2.06,"value":1932.28,"ownership":{"direct":true},"balance_after":78160,"source":{"system":"sec-edgar","filing":"0001437749-23-007564","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923007564/rdgdoc.xml","form_type":"4"}},{"id":1961975,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-10T00:00:58.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":31,"price":22.95,"value":711.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":77222,"source":{"system":"sec-edgar","filing":"0001437749-23-006042","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923006042/rdgdoc.xml","form_type":"4"}},{"id":1976695,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-04T00:00:21.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":1576,"price":22.75,"value":35854.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":77253,"source":{"system":"sec-edgar","filing":"0001437749-23-005438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923005438/rdgdoc.xml","form_type":"4"}},{"id":1997380,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-24T00:00:29.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":117,"price":21.47,"value":2511.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":78829,"source":{"system":"sec-edgar","filing":"0001437749-23-004430","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923004430/rdgdoc.xml","form_type":"4"}},{"id":2058062,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Award","published_at":"2023-01-11T00:00:50.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":34295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."}],"balance_after":34295,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":34295},"source":{"system":"sec-edgar","filing":"0001437749-23-000815","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923000815/rdgdoc.xml","form_type":"4"}},{"id":2058061,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-11T00:00:50.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":34295,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the \"Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2023 compensation."}],"balance_after":78946,"source":{"system":"sec-edgar","filing":"0001437749-23-000815","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923000815/rdgdoc.xml","form_type":"4"}},{"id":2077202,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-24T00:00:28.000Z","date":"2022-12-22","kind":"sale","acquired":false,"shares":528,"price":17.55,"value":9266.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":44651,"source":{"system":"sec-edgar","filing":"0001437749-22-029734","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922029734/rdgdoc.xml","form_type":"4"}},{"id":2101880,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-01T01:01:26.000Z","date":"2022-11-29","kind":"sale","acquired":false,"shares":52,"price":19.93,"value":1036.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":45179,"source":{"system":"sec-edgar","filing":"0001437749-22-028235","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922028235/rdgdoc.xml","form_type":"4"}},{"id":2105909,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-24T01:00:48.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":121,"price":20.2,"value":2444.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":45231,"source":{"system":"sec-edgar","filing":"0001437749-22-028059","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922028059/rdgdoc.xml","form_type":"4"}},{"id":2151560,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-27T00:08:08.000Z","date":"2022-09-23","kind":"sale","acquired":false,"shares":569,"price":21.91,"value":12466.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":45352,"source":{"system":"sec-edgar","filing":"0001437749-22-023077","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922023077/rdgdoc.xml","form_type":"4"}},{"id":2169464,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-02T00:02:13.000Z","date":"2022-08-31","kind":"sale","acquired":false,"shares":51,"price":23.44,"value":1195.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":45921,"source":{"system":"sec-edgar","filing":"0001437749-22-021728","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922021728/rdgdoc.xml","form_type":"4"}},{"id":2180240,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-19T00:05:16.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":116,"price":24.81,"value":2877.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":45972,"source":{"system":"sec-edgar","filing":"0001437749-22-020999","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922020999/rdgdoc.xml","form_type":"4"}},{"id":2184916,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-17T00:00:18.000Z","date":"2022-08-14","kind":"grant","acquired":true,"shares":234,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":46088,"source":{"system":"sec-edgar","filing":"0001437749-22-020749","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922020749/rdgdoc.xml","form_type":"4"}},{"id":2198308,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-03T00:00:31.000Z","date":"2022-07-29","kind":"grant","acquired":true,"shares":299,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":45854,"source":{"system":"sec-edgar","filing":"0001437749-22-018509","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922018509/rdgdoc.xml","form_type":"4"}},{"id":2205834,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-20T00:00:42.000Z","date":"2022-07-17","kind":"grant","acquired":true,"shares":362,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":45555,"source":{"system":"sec-edgar","filing":"0001437749-22-017382","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922017382/rdgdoc.xml","form_type":"4"}},{"id":2213266,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-07T00:03:05.000Z","date":"2022-07-03","kind":"grant","acquired":true,"shares":394,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":45193,"source":{"system":"sec-edgar","filing":"0001437749-22-016769","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922016769/rdgdoc.xml","form_type":"4"}},{"id":2220578,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-29T00:00:47.000Z","date":"2022-06-24","kind":"sale","acquired":false,"shares":456,"price":15.95,"value":7273.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":44799,"source":{"system":"sec-edgar","filing":"0001437749-22-016098","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922016098/rdgdoc.xml","form_type":"4"}},{"id":2226180,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-22T00:01:42.000Z","date":"2022-06-19","kind":"grant","acquired":true,"shares":418,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":45255,"source":{"system":"sec-edgar","filing":"0001437749-22-015534","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922015534/rdgdoc.xml","form_type":"4"}},{"id":2240895,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-08T00:00:21.000Z","date":"2022-06-05","kind":"grant","acquired":true,"shares":419,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":44837,"source":{"system":"sec-edgar","filing":"0001437749-22-014537","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922014537/rdgdoc.xml","form_type":"4"}},{"id":2250245,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-02T00:01:28.000Z","date":"2022-05-27","kind":"sale","acquired":false,"shares":43,"price":14.53,"value":624.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":44418,"source":{"system":"sec-edgar","filing":"0001437749-22-014060","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922014060/rdgdoc.xml","form_type":"4"}},{"id":2258973,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-25T00:04:38.000Z","date":"2022-05-22","kind":"grant","acquired":true,"shares":448,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":44461,"source":{"system":"sec-edgar","filing":"0001437749-22-013466","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922013466/rdgdoc.xml","form_type":"4"}},{"id":2269350,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-18T00:00:43.000Z","date":"2022-05-13","kind":"sale","acquired":false,"shares":125,"price":12.32,"value":1540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":44013,"source":{"system":"sec-edgar","filing":"0001437749-22-012844","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922012844/rdgdoc.xml","form_type":"4"}},{"id":2319291,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-25T00:00:58.000Z","date":"2022-03-22","kind":"sale","acquired":false,"shares":551,"price":23.06,"value":12706.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":44138,"source":{"system":"sec-edgar","filing":"0001437749-22-007141","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922007141/rdgdoc.xml","form_type":"4"}},{"id":2343010,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Award","published_at":"2022-03-10T02:22:50.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":23365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2022 through December 31, 2023 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2022 through December 31, 2023 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2022 through December 31, 2023 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."}],"balance_after":23365,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":23365},"source":{"system":"sec-edgar","filing":"0001437749-22-005778","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922005778/rdgdoc.xml","form_type":"4"}},{"id":2343009,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-10T02:22:50.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":23365,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the \"Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2022 compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount represented in Column 5 of Table I reflects the amount of securities beneficially owned by the reporting person as of the transaction date reported herein. It does not give effect to the transaction reported by the reporting person on the Form 4 filed by the reporting person on March 3, 2022."}],"balance_after":44745,"source":{"system":"sec-edgar","filing":"0001437749-22-005778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922005778/rdgdoc.xml","form_type":"4"}},{"id":2357444,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-04T01:00:40.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":56,"price":23.78,"value":1331.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":21324,"source":{"system":"sec-edgar","filing":"0001437749-22-005227","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922005227/rdgdoc.xml","form_type":"4"}},{"id":2390031,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-18T01:29:13.000Z","date":"2021-11-30","kind":"sale","acquired":false,"shares":33,"price":37.59,"value":1240.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"On December 2, 2021, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares."}],"balance_after":22432,"source":{"system":"sec-edgar","filing":"0001437749-22-003763","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922003763/rdgdoc.xml","form_type":"4/A","original_submission_date":"2021-12-02"}},{"id":2390030,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-18T01:28:08.000Z","date":"2021-12-22","kind":"sale","acquired":false,"shares":310,"price":38.49,"value":11931.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"On December 23, 2021, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares."}],"balance_after":22122,"source":{"system":"sec-edgar","filing":"0001437749-22-003762","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922003762/rdgdoc.xml","form_type":"4/A","original_submission_date":"2021-12-23"}},{"id":2390029,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-18T01:26:49.000Z","date":"2022-01-07","kind":"sale","acquired":false,"shares":47,"price":30.75,"value":1445.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"On January 11, 2022, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares."}],"balance_after":22075,"source":{"system":"sec-edgar","filing":"0001437749-22-003761","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922003761/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-01-11"}},{"id":2390028,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-18T01:00:21.000Z","date":"2022-02-15","kind":"sale","acquired":false,"shares":695,"price":26.57,"value":18466.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":21380,"source":{"system":"sec-edgar","filing":"0001437749-22-003759","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922003759/rdgdoc.xml","form_type":"4"}}],"next_cursor":"2022-02-18T01:00:21.000000Z,2390028"}